A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.
Astellas Pharma Inc
Astellas Pharma Inc
AstraZeneca
University of Milano Bicocca
Stanford University
University of Zurich
Jules Bordet Institute
Massachusetts General Hospital
Paradigm Health
European Institute of Oncology
Centre Hospitalier Universitaire de Saint Etienne
Carol Davila University of Medicine and Pharmacy
Heinrich-Heine University, Duesseldorf
University Hospital, Toulouse
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bristol-Myers Squibb
European Institute of Oncology
European Institute of Oncology